Establishment Labs Holdings Operating Margin 2017-2024 | ESTA

Current and historical operating margin for Establishment Labs Holdings (ESTA) over the last 10 years. The current operating profit margin for Establishment Labs Holdings as of June 30, 2024 is -54.97%.
Establishment Labs Holdings Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-06-30 $0.15B $-0.06B -40.13%
2024-03-31 $0.16B $-0.07B -42.04%
2023-12-31 $0.17B $-0.07B -38.92%
2023-09-30 $0.18B $-0.06B -31.28%
2023-06-30 $0.18B $-0.05B -25.84%
2023-03-31 $0.17B $-0.04B -24.71%
2022-12-31 $0.16B $-0.04B -24.84%
2022-09-30 $0.15B $-0.04B -23.68%
2022-06-30 $0.14B $-0.03B -23.78%
2022-03-31 $0.13B $-0.03B -21.64%
2021-12-31 $0.13B $-0.03B -19.84%
2021-09-30 $0.12B $-0.02B -20.34%
2021-06-30 $0.11B $-0.02B -16.07%
2021-03-31 $0.09B $-0.02B -25.56%
2020-12-31 $0.08B $-0.03B -34.52%
2020-09-30 $0.08B $-0.03B -30.86%
2020-06-30 $0.08B $-0.03B -38.27%
2020-03-31 $0.09B $-0.03B -32.26%
2019-12-31 $0.09B $-0.03B -33.33%
2019-09-30 $0.08B $-0.04B -42.68%
2019-06-30 $0.08B $-0.03B -42.67%
2019-03-31 $0.07B $-0.03B -43.28%
2018-12-31 $0.06B $-0.02B -39.34%
2018-09-30 $0.06B $-0.02B -35.09%
2018-06-30 $0.05B $-0.02B -41.67%
2018-03-31 $0.04B $-0.02B -44.19%
2017-12-31 $0.04B $-0.02B -57.14%
Sector Industry Market Cap Revenue
Medical Medical Services $1.314B $0.165B
Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $121.497B 14.81
Cencora (COR) United States $44.320B 16.94
ICON (ICLR) Ireland $23.561B 21.17
DiDi Global (DIDIY) China $23.282B 0.00
Avantor (AVTR) United States $17.560B 26.63
Natera (NTRA) United States $15.549B 0.00
Revvity (RVTY) United States $15.548B 27.23
Viatris (VTRS) United States $13.785B 4.20
CochLear (CHEOY) Australia $12.759B 0.00
Solventum (SOLV) United States $11.670B 0.00
Medpace Holdings (MEDP) United States $10.275B 31.18
Charles River Laboratories (CRL) United States $10.239B 19.35
Sonic Healthcare (SKHHY) Australia $9.066B 0.00
Doximity (DOCS) United States $7.965B 50.47
HealthEquity (HQY) United States $6.980B 37.88
Bausch + Lomb (BLCO) Canada $6.671B 28.71
PACS (PACS) United States $6.029B 0.00
Organon (OGN) United States $4.938B 5.02
Life Times (LTH) United States $4.827B 40.35
Sotera Health (SHC) United States $4.747B 23.94
Surgery Partners (SGRY) United States $4.058B 44.96
Concentras Parent (CON) United States $2.838B 0.00
Ardent Health Partners (ARDT) United States $2.613B 0.00
GoodRx Holdings (GDRX) United States $2.599B 97.86
BrightSpring Health Services (BTSG) United States $2.570B 0.00
Alignment Healthcare (ALHC) United States $2.194B 0.00
Premier (PINC) United States $2.003B 9.00
Ryman Healthcare (RYHTY) New Zealand $1.961B 0.00
AMN Healthcare Services Inc (AMN) United States $1.618B 8.12
CareDx (CDNA) United States $1.566B 0.00
Agilon Health (AGL) United States $1.539B 0.00
Progyny (PGNY) United States $1.517B 26.67
Teladoc Health (TDOC) United States $1.449B 0.00
GeneDx Holdings (WGS) United States $1.153B 0.00
QDM (QDMI) Hong Kong, SAR China $1.123B 29.39
Pediatrix Medical (MD) United States $0.967B 10.52
Embecta (EMBC) United States $0.817B 5.45
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.531B 0.00
Sharecare (SHCR) United States $0.524B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.466B 0.00
Enhabit (EHAB) United States $0.399B 34.48
Sonida Senior Living (SNDA) United States $0.378B 0.00
DocGo (DCGO) United States $0.346B 13.00
Sera Prognostics (SERA) United States $0.256B 0.00
Biodesix (BDSX) United States $0.248B 0.00
LifeMD (LFMD) United States $0.224B 0.00
ModivCare (MODV) United States $0.200B 6.34
Ascend Wellness Holdings (AAWH) United States $0.181B 0.00
Beauty Health (SKIN) United States $0.171B 0.00
MultiPlan (MPLN) United States $0.118B 0.00
Nutex Health (NUTX) United States $0.099B 0.00
So-Young (SY) China $0.093B 22.49
Harvard Apparatus Regenerative Technology (HRGN) United States $0.087B 0.00
SBC Medicals (SBC) United States $0.050B 0.00
NeueHealth (NEUE) United States $0.042B 1.69
Co-Diagnostics (CODX) United States $0.039B 0.00
Singular Genomics Systems (OMIC) United States $0.039B 0.00
OncoCyte (OCX) United States $0.039B 0.00
Pheton Holdings (PTHL) China $0.032B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
IceCure Medical (ICCM) Israel $0.029B 0.00
Oncology Institute (TOI) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.018B 0.00
XWELL (XWEL) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
KindlyMD (KDLY) $0.007B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00